Pharmaceutical Isoprinosine Powder Material Isoprinosine Purity Isoprinosine

• Customization: Available
• Powder: Powder
• Customized: Customized
• Model NO.: D-sung Isoprinosine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Isoprinosine
• Name: Isoprinosine Powder
• Appearance: White Powde
• Color: White
• Specific: COA
• Grade: Pharmaceutical Grade
• Assay: 99%
• Application: Pharmaceutical
• Test Method: HPLC Tlc
• CAS: 36703-88-5
• Mf: C24h34n6o9
• MW: 550.57
• Melting Point: 140-142
• Shelf Life: 2 Years
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Pharmaceutical Intermediates Isoniazid Purity Isoniazid Powder Material Isoniazid

Product Description

Product Details

 

Product Name	Isoprinosine
CAS NO.	36703-88-5
Purity	99%
Molecular Weight	1115.23
Appearance and shape	White powder

Isoprinosine (also known as inosine pranobex) an antiviral drug combing of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. It is mainly used for treating the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy1,2. In UK, it is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type 2) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser1. It also has certain efficacy in the treatment of AIDS and some other acquired immunodeficiency such as aged patients, cancer patients, severely burned patients, ill patients, and surgery patients.

Application&Function

1. For a variety of viral infections, including subacute sclerosing panencephalitis, acute viral meningitis, herpes zoster, skin herpes, influenza and thrush, herpesvirus keratitis, uveitis, acquired immunity Defect syndrome (AIDS), immunodeficiency disease and so on.
2. As a therapeutic agent for malignant lymphoma, myeloma, early malignant melanoma, combined with surgery for the treatment of esophageal cancer, gastric cancer, rectal cancer, thyroid cancer patients.

Specification